AFT Pharmaceuticals is an Australasian pharmaceutical company founded by husband and wife – Hartley and Marree Atkinson. AFT Pharmaceuticals produces over 130 over-the-counter and prescription medications, with their most popular drug being opioid-alternative Maxigesic.

After starting in New Zealand, they now operate out of offices in Singapore, Kuala Lumpur, Sydneym and Auckland. AFT Pharmaceuticals currently sells products in 109 countries worldwide and owns the brands Crystaderm, coco-scalp and MyDryEyes. The company also runs the Orphan Drugs Foundation, which is a non-profit that provides affordable medications to sufferers of rare diseases in the Pacific and South-East Asia. 

AFT Pharmaceuticals entered the medical cannabis market in 2020, after signing an agreement to source pharmaceutical-grade medicinal cannabis from New Zealand-based producer Setek. 

AFT Pharmaceuticals is publicly listed on the ASX and on the NZX as AFP.